Pro Share Advisors LLC Intra Cellular Therapies, Inc. Transaction History
Pro Share Advisors LLC
- $39.7 Billion
- Q3 2024
A detailed history of Pro Share Advisors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 6,244 shares of ITCI stock, worth $795,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,244
Previous 19,965
68.73%
Holding current value
$795,173
Previous $1.37 Million
66.64%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ITCI
# of Institutions
381Shares Held
84MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$1.23 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$805 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$673 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$490 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$388 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...